USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
ANALYTICAL BIOLOGICAL SERVICES, INC.
Address:
ANALYTICAL BIOLOGICAL SERVICES
701-4 CORNELL BUSINESS PARK
WILMINGTON, DE 19801
Phone:
(302) 654-4492
URL:
N/A
EIN:
510324951
DUNS:
N/A
Number of Employees:
N/A
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $625,188.00 8
SBIR Phase II $1,596,218.00 3
STTR Phase I $199,150.00 3
STTR Phase II $749,694.00 1

Award List:

USE OF ROBOTICS IN AUTOMATIC FACTORY ASSEMBLY

Award Year / Program / Phase:
1984 / SBIR / Phase I
Award Amount:
$50,000.00
Agency / Branch:
DOD / NAVY
Principal Investigator:
Shafi Motiwalla
Abstract:
N/a

USE OF ROBOTICS IN AUTOMATIC FACTORY ASSEMBLY

Award Year / Program / Phase:
1985 / SBIR / Phase II
Award Amount:
$249,568.00
Agency / Branch:
DOD / NAVY
Principal Investigator:
Shafi Motiwalla
Abstract:
This project will investigate the technical feasibility of using a cluster controller and off-line program development system for a cluster of industrial robots, programmable controllers and vision systems in a factory environment for the purpose of low volume assembly. the following issues will be… More

Nonradioactive Receptor Binding Assays

Award Year / Program / Phase:
1995 / SBIR / Phase I
Award Amount:
$76,286.00
Agency:
HHS
Principal Investigator:
Charles Saller
Abstract:
The use of biotin labeled ligands in receptor binding assays will be used as a substitute for radioHigh affinity biotinylated ligands are used in immunochemistry studies but are not generally employebinding experiments. Biotinylated ligands also have high affinities for the proteins avidin and… More

RECEPTOR BINDING AND ENZYME ASSAYS USING BIOSOMES TM

Award Year / Program / Phase:
1997 / SBIR / Phase I
Award Amount:
$100,000.00
Agency:
HHS
Principal Investigator:
Saller, charles f
Abstract:
The proposed research is aimed at developing a new molecular recognition technology for drug discovery. Stable liposome-based biosensors, called Biosomes TM, turn from blue to red in response to a specific molecular recognition event. The Biosomes can be functionalized with a specific receptor… More

N/A

Award Year / Program / Phase:
1999 / SBIR / Phase II
Award Amount:
$846,902.00
Agency:
HHS
Principal Investigator:
Saller charles f
Abstract:
N/a

AN ULTRA HIGH THROUGHPUT SYSTEM FOR DRUG DISCOVERY

Award Year / Program / Phase:
1999 / SBIR / Phase I
Award Amount:
$103,007.00
Agency:
HHS
Principal Investigator:
Sarah A. Sporn
Abstract:
N/a

N/A

Award Year / Program / Phase:
2001 / SBIR / Phase I
Award Amount:
$97,456.00
Agency:
NSF
Principal Investigator:
Abstract:
This Small Business Innovation Research Phase I (SBIR) project will develop a novel sensing coating that will be deposited on filters for the detection of water-borne contaminants. The initial target will be the oocysts of Cryptosporidium parvum, a water- borne pthogen. C. Parvum was responsible for… More

Fluorescent Liposomes for Detection of Biological Warfare Agent Toxins in Water

Award Year / Program / Phase:
2002 / STTR / Phase I
Award Amount:
$99,455.00
Agency / Branch:
DOD / ARMY
Principal Investigator:
Mary Reppy, Director of Chemical Research
Research Institution:
Sri International
RI Contact:
Rachel Stahl
Abstract:
"Reliable and sensitive detection of potential biowarfare agent (BWA) toxins such as botulinum toxin, staphylococcal enterotoxin, saxitoxin, etc., is an important challenge during both military operations and for domestic anti-terrorism efforts. We proposeto develop biomimetic polymerized… More

New Materials for Plague Antigen and Antibody Detection

Award Year / Program / Phase:
2003 / SBIR / Phase I
Award Amount:
$98,530.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): We propose to develop novel soluble sensing materials that can be used in homogenous fluorescence assays for the detection of Yersinia pestis antigens and antibodies. Y. pestis is the etiological cause of plague and a potential biowarfare agent. The sensing… More

SBIR Phase II: Development of a Novel Sensing Material for Waterborne Pathogens

Award Year / Program / Phase:
2003 / SBIR / Phase II
Award Amount:
$499,748.00
Agency:
NSF
Principal Investigator:
Mary Reppy
Abstract:
This Small Business Innovation Research (SBIR) Phase II Project proposes to develop a method to detect Cryptosporidium parvum oocyst in water using a novel sensing coating deposited on filters. C. parvum has been responsible for a number of outbreaks of cryptosporidiosis, including the outbreak in… More

SBIR Phase II: Development of a Novel Sensing Material for Waterborne Pathogens

Award Year / Program / Phase:
2003 / SBIR / Phase I
Award Amount:
$0.00
Agency:
NSF
Principal Investigator:
Mary Reppy
Abstract:
This Small Business Innovation Research (SBIR) Phase II Project proposes to develop a method to detect Cryptosporidium parvum oocyst in water using a novel sensing coating deposited on filters. C. parvum has been responsible for a number of outbreaks of cryptosporidiosis, including the outbreak in… More

High-throughput Prediction of Compound Tissue Distribution

Award Year / Program / Phase:
2006 / SBIR / Phase I
Award Amount:
$99,909.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): The aim of the proposed research is to develop tools for the prediction of the distribution of drug compounds in the human body. There is currently no experimental high throughput screening (HTS) method for determining compound tissue distribution. A drug… More